Unusual Movements in BSE 500 Stocks; 05 May 2026
By Prime Research | Updated at: May 5, 2026 04:24 PM IST
Open Free Demat Account
Wockhardt Pharma (+9.6%): The company reported its Q4FY26 results on Monday, after market hours. In the March quarter (Q4FY26), Wockhardt posted net profit year-on-year (Y-o-Y) of ₹166 crore, as compared to a net loss of ₹25 crore a year ago. Its revenue came in at ₹965 crore, as compared to ₹743 crore a year ago, up 30 per cent.
Tata Tech(+8.3%): Company reported a consolidated net profit of Rs 204 crore for the March quarter, up 8% from Rs 189 crore in the same period last year. The profit is attributable to the company’s shareholders. Revenue from operations for Q4 came in at Rs 1,572 crore, marking a 22% increase from Rs 1,286 crore in the year-ago quarter.
CAMS(+6.1%): Company reported a 10.9% year-on-year rise in consolidated net profit for the fourth quarter at ₹126 crore, compared with ₹114 crore in the same period last year. Revenue for the quarter increased 11% year-on-year to ₹395.2 crore from ₹356.2 crore earlier.
Aarti Ind (-6.9%): Net profit of Aarti Industries rose 42.71% to Rs 137.00 crore in the quarter ended March 2026 as against Rs 96.00 crore during the previous quarter ended March 2025. Sales rose 13.13% to Rs 2205.00 crore in the quarter ended March 2026 as against Rs 1949.00 crore during the previous quarter ended March 2025.
Disclaimer
At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please Note: The information shared is intended solely for informational purposes and does not make any investment recommendations
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please Note: The information shared is intended solely for informational purposes and does not make any investment recommendations
